Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent.

The New England journal of medicine ·Vol. 277 ·No. 22 ·1967-11-30 ·Pages 1168-73

Sasahara AA, Cannilla JE, Belko JS, Morse RL, Criss AJ

Abstract

暂无摘要

MeSH Terms

Adult Aged Blood Coagulation Blood Gas Analysis Blood Pressure/drug effects Fibrinolysis/drug effects Fibrinolytic Agents/adverse effects,therapeutic use Heparin/therapeutic use Humans Hypertension, Pulmonary Male Middle Aged Pulmonary Artery/diagnostic imaging Pulmonary Embolism/diagnosis,drug therapy Radiography Radionuclide Imaging

Chemicals

Fibrinolytic Agents Heparin

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Sasahara A A

Cannilla J E

Belko J S

Morse R L

Criss A J

Article Info

Journal

The New England journal of medicine

Abbr.

N Engl J Med

ISSN

0028-4793

DOI

10.1056/NEJM196711302772203

Published

1967-11-30

Pages

1168-73

Language

English

Region

United States

NLM ID

0255562

Subset

External Links

PubMed source DOI: 10.1056/NEJM196711302772203 View journal details

Analysis Services

Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent.

Contact

WeChat Official Account